Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 3Myelodysplastic Syndromes 2Neutropenia 1Mycoses 1Anemia, Aplastic 1

Interventions

pegfilgrastim 3Vancomycin 2Teicoplanin 2Meropenem 2Filgrastim 2Ciprofloxacin 2Ceftazidime 2Cefepime 2posaconazole 1pegylated granulocyte colony-stimulating factor 1Vascular Access Devices 1Ofloxacin 1Metronidazole 1Leucovorin 1Lenograstim 1Irinotecan 1Fluorouracil 1Cilastatin, Imipenem Drug Combination 1Amikacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Neutropenia × posaconazole × Clear all
NCT00686543 2017-04-07

Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)

Merck Sharp & Dohme LLC

Phase 4 Completed
75 enrolled 14 charts
Other hematologic neoplasm

Mycoses, Neutropenia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡